Caplight Directory>Companies>Cayuga Biotech-preview>Cayugabiotech


Cayuga Biotech

Cayuga Biotech

Private
New York City, New YorkHealthcare & Life Scienceshttps://cayugabiotech.com

Last Round

Seed

Dec 11, 2025

Total Funding Raised

$5.4M

Momentum Score

25 /100

Company Overview

Cayuga Biotech is a biotechnology company that develops novel therapeutics to address life-threatening hemorrhage and bleeding disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

hemorrhage controlblood clotting druginjectable hemostathemostatic agenttrauma drugbattlefield medicineprocoagulantpolyphosphate therapyblood thinner reversalbiomimetic therapyclinical-stage biotechdrug developmentcombat casualty careB2Gdual-use technologyinherited bleeding disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cayuga Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cayuga Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 11, 2025
AcceleratorMay 1, 2020
GrantOct 16, 2019
View all Funding Rounds

Cayuga Biotech Investors

Notable investors and investment history

InvestorRounds
TBD AngelsSeed
Wharton Alumni AngelsSeed
Walnut VenturesSeed
U.S. ArmyGrant
IndieBioAccelerator
New York VenturesSeed
Purchase CapitalSeed
View all Investors

Cayuga Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cayuga Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cayuga Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2015
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.